The biopharma cold chain logistics market covers the specialized storing, handling, and transporting of temperature-sensitive pharmaceutical and biotechnology products. These include vaccines, biologics, blood products, certain drugs, and cell and gene therapies. According to Polaris Market Research, the market was valued at USD 18.23 billion in 2024 and is anticipated to grow at a CAGR of 10.98% from 2025 to 2034. It is estimated at USD 20.20 billion in 2025 and is projected to reach USD 51.58 billion by 2034, with North America the largest market in 2024.

Demand Drivers Shaping Buyer Decisions

Polaris identifies the high prevalence of chronic diseases, growth in healthcare expenditure and R&D, and regulatory compliance as the key factors driving demand. Rising demand for over-the-counter (OTC) drugs is also propelling adoption, and the global rise in chronic conditions is creating a lucrative market opportunity. For B2B buyers such as pharmaceutical manufacturers and distributors, these forces reinforce the need for dependable, end-to-end handling. The cold chain is an integrated system of refrigerated storage facilities, temperature-controlled packaging, and specialized transportation modes, and every link must preserve product integrity. Other factors favoring growth include the rising importance of fast-track delivery through technology and cost containment measures to maintain optimal distribution and packaging costs.

Browse Full Insights:

https://www.polarismarketresearch.com/industry-analysis/biopharma-cold-chain-logistics-market

Storage Leads the Component Landscape

By component, the market is segmented into storage, transportation, and monitoring components. Storage accounted for the largest revenue share in 2024, driven by a surge in demand for temperature-sensitive nutritional supplements and temperature-sensitive vaccines. Within storage, the report covers warehouses and refrigerated containers, while transportation spans sea, air, and overland modes. The ageing population in emerging countries such as India and China also lifted demand for storage solutions for vaccines developed in those nations, and growing healthcare spending, particularly in India and Brazil, further supported the segment's dominance.

Monitoring Technologies Improve Visibility

Monitoring components span hardware, including sensors, RFID devices, telematics, and networking devices, as well as software. According to the report, IoT allows real-time monitoring of temperature, humidity, and other environmental conditions during storage and transit, which supports product integrity and compliance. Polaris also notes that AI strengthens real-time monitoring through IoT-enabled sensors while helping reduce transit times. Industry examples include Maersk, which uses IoT-enabled refrigerated containers to protect consignments from adulteration, misplacement, and theft, and SkyCell, which offers refrigerated containers designed for pharmaceutical products. In September 2020, DHL Global Forwarding launched its New LifeTrack User Interface, a temperature-controlled shipment tracking portal offering real-time analytics and a lane risk assessment tool.

Regional Outlook and Competitive Dynamics

North America accounted for the largest revenue share in 2024, owing to the presence of major players. The U.S. and Canada both have well-developed pharma logistics and distribution infrastructure, and companies there are investing in newer technologies and supply chain processes to minimize wastage and losses. Asia Pacific is projected to be the fastest-growing region, owing to rapid economic strides in emerging economies such as India and Thailand. Polaris describes the competitive field as evolving quickly, with players expanding cold storage networks and strengthening compliance with strict global standards. In April 2025, DHL Group announced plans to invest EUR 2 billion by 2030 in DHL Health Logistics. The report also cautions that the high cost of biopharma cold chain logistics may hamper market growth.

Key Players

•         Air Canada

•         DB Schenker

•         Kuehne+Nagel

•         Agility

•         Deutsche Post AG

•         United Parcel Service of America, Inc.

•         Deutsche Post DHL

•         LifeConEx

•         VersaCold Logistics Services

•         Panalpina World Transport

•         Marken

•         FedEx

•         CEVA Logistics

Conclusion

The biopharma cold chain logistics market is positioned for steady expansion as temperature-sensitive therapies become more central to healthcare delivery. With a value of USD 18.23 billion in 2024 and a forecast of USD 51.58 billion by 2034 at a CAGR of 10.98%, the sector rewards providers that pair strong storage capacity with reliable monitoring. Stakeholders evaluating logistics partners should weigh infrastructure depth, digital visibility, and regional presence, while keeping cost pressure in view.

More Trending Latest Reports By Polaris Market Research:

Gynecological Examination Chairs Market

Fluoropolymers Market

Safari Tourism Market

Enterprise Content Management Market

Automotive Ceramics Market

Mass Flow Controller Market

Hemophilia A Treatment Market

AI Trust, Risk and Security Management Market